KRISTINA TODD: Open Payments
NPI 1285057265 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,301 in 129 payments from 23 companies in 2025. Trend: 2023 $2,522 · 2024 $2,549 · 2025 $2,301
Food & beverage: $2,129Education: $172
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $346 |
| Regeneron Healthcare Solutions, Inc. | 16 | $288 |
| UCB, Inc. | 18 | $287 |
| LEO Pharma Inc. | 12 | $228 |
| Novartis Pharmaceuticals Corporation | 11 | $187 |
| ABBVIE INC. | 10 | $162 |
| GENZYME CORPORATION | 5 | $135 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Galderma Laboratories, L.P. | 5 | $78 |
| Lilly USA, LLC | 3 | $70 |
Products named: DUPIXENT, TREMFYA, Bimzelx, ADBRY, COSENTYX, SKYRIZI, ANZUPGO, OTEZLA.
Industry payments across AZ — which companies pay providers there.
